BSE filing, NSE: ALIVUS. Summary written from the filing by ALFA Finder's alert engine.
Alivus Life Sciences Ltd: key numbers
- Share price
- ₹1,395.00
- Market cap
- ₹17,127 Cr
- Revenue (annual)
- ₹2,552 Cr
- Net profit (annual)
- ₹564.5 Cr
- P/E (TTM)
- 28.4×Sector 46.1×
- Promoter holding
- 74.85%-0.02% QoQ
- FII holding
- 5.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alivus Life Sciences Ltd
All →Alivus Life Sciences Board Meeting Date
Alivus Life Sciences Ltd has scheduled a Board Meeting on October 29, 2026, to consider and approve its unaudited financial results for the period ended September 30, 2026.
Alivus Life Sciences Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Alivus Life Sciences Legal & Regulatory
Alivus Life Sciences Limited received a GST order for FY 2020-22 involving a tax demand and penalty of Rs. 0.51 Crore. The company is currently assessing an appeal.
- Value
- ₹0.51 Cr
Alivus Life Sciences Acquisition Worth ₹14.04 Cr
Alivus Life Sciences acquired a 9.21% stake in Torrent Urja 19 Private Limited for Rs. 14.04 Crore. The investment supports its renewable energy and carbon neutrality goals.
- Value
- ₹14.04 Cr
Alivus Life Sciences Merger & Restructuring Worth ₹0.9 Cr
Alivus Life Sciences incorporated a wholly owned pharma subsidiary in Brazil. The company subscribes up to R$500,000 (₹0.90 Cr) for 100% of the new entity.
- Value
- ₹0.90 Cr
Alivus Life Sciences Annual General Meeting
Alivus Life Sciences Limited successfully conducted its 15th Annual General Meeting on September 8, 2026. All resolutions proposed in the AGM notice were passed with requisite majority.
Other board meeting date announcements
All →Vascon Engineers Board Meeting Date
Vascon Engineers has scheduled a board meeting on November 3, 2026 for quarterly results and NCD fund raising. Trading window stays closed until results are declared.
Ruchi Infrastructure Board Meeting Date
Ruchi Infrastructure schedules a board meeting on 4 November 2026 to approve unaudited quarterly and half-year results. Trading window remains closed until 6 November 2026.
Swastika Castal Board Meeting Date
Swastika Castal will hold a board meeting on 4 November 2026 to consider unaudited results for period ended 30 September 2026. Trading window stays closed until results.
GTL Board Meeting Date
GTL Ltd will hold a board meeting on 5 November 2026 to consider unaudited results for quarter ended 30 September 2026. Results are proposed until the meeting.
Acetech E-Commerce Board Meeting Date
Acetech E-Commerce will hold a board meeting on 03-Nov-2026 to consider a fund raise through a rights issue and other business. The trading window stays closed until 48 hours after the outcome is disseminated.
Camlin Fine Sciences Board Meeting Date
Camlin Fine Sciences' board meets on 03 Nov 2026 to consider results and a proposed rights issue. Trading window closes until 05 Nov 2026.